AI Analysis AI Analysis of ZBH AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ZBH to Watchlist?
Some Reasons Why To Add ZBH:
  • Excellent financial health (Piotroski 8/9)
  • Beat earnings estimates in 3 of the last 4 quarters
  • High gross margin of 70.0%
PDF

Zimmer Biomet Holdings stock upgraded from Hold/Accumulate to Buy Candidate after Thursday trading session
(Updated on Jul 23, 2026)

Buy or Hold candidate since Jul 16, 2026 Loss -4.37%

The Zimmer Biomet Holdings stock price gained 1.09% on the last trading day (Thursday, 23rd Jul 2026), rising from $88.68 to $89.65. During the last trading day the stock fluctuated 2.29% from a day low at $88.25 to a day high of $90.27. The price has fallen in 6 of the last 10 days but is still up by 0.47% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 857 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $144.09 million.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 9.52% during the next 3 months and, with a 90% probability hold a price between $94.42 and $104.65 at the end of this 3-month period.

ZBH Signals & Forecast

The Zimmer Biomet Holdings stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $90.27. On a fall, the stock will find some support from the long-term average at approximately $89.00. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 13, 2026, and so far it has fallen -4.71%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Zimmer Biomet Holdings stock

On the downside, the stock finds support just below today's level from accumulated volume at $82.80 and $82.43. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Zimmer Biomet Holdings finds support just below today's level at $82.80. If this is broken, then the next support from accumulated volume will be at $82.43 and $80.07.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.02 between high and low, or 2.29%. For the last week, the stock has had daily average volatility of 2.44%.

Our recommended stop-loss: $85.12 (-5.05%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (ZBH) For The Upcoming Trading Day Of Friday 24th

For the upcoming trading day on Friday, 24th we expect Zimmer Biomet Holdings to open at $89.39, and during the day (based on 14 day Average True Range), to move between $88.24 and $91.06, which gives a possible trading interval of +/-$2.83 (+/-3.21%) up or down from last closing price. If Zimmer Biomet Holdings takes out the full calculated possible swing range there will be an estimated 3.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $91.03 (1.54%) than the support at $82.80 (7.64%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Zimmer Biomet Holdings stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Zimmer Biomet Holdings stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 3.315 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 24, 2026 - $89.39 ( 0.290%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ZBH Performance

Trading levels for ZBH

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 91.41 1.96%
R2 90.64 1.10%
R1 90.16 0.571%
Price 89.65
S1 88.62 -1.15%
S2 88.14 -1.68%
S3 87.37 -2.54%

Accumulated Volume Support & Resistance Levels

Level Price
R3 94.08 4.94%
R2 93.75 4.57%
R1 91.03 1.54%
Price 89.65
S1 82.80 -7.64%
S2 82.43 -8.05%
S3 80.07 -10.69%

ZBH Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 25, 2026 Jun 25, 2026 Jul 31, 2026 $0.240 0.284%
2 Feb 23, 2026 Mar 31, 2026 Apr 30, 2026 $0.240 0.238%
3 Dec 30, 2025 Dec 30, 2025 Jan 30, 2026 $0.240 0.265%
4 Aug 27, 2025 Sep 30, 2025 Oct 31, 2025 $0.240 0.226%
5 May 30, 2025 Jun 26, 2025 Jul 31, 2025 $0.240 0.261%

FAQ

What is the symbol for Zimmer Biomet Holdings Stock and on which exchange is it traded?
The symbol for Zimmer Biomet Holdings is ZBH and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Zimmer Biomet Holdings Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Zimmer Biomet Holdings stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

How to buy Zimmer Biomet Holdings Stock?
Zimmer Biomet Holdings Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Zimmer Biomet Holdings Stock.

What's the current price of Zimmer Biomet Holdings Stock?
As of the end of day on the Jul 23, 2026, the price of an Zimmer Biomet Holdings (ZBH) share was $89.65.

What is the 52-week high and low for Zimmer Biomet Holdings Stock?
The 52-week high for Zimmer Biomet Holdings Stock is $108.29 and the 52-week low is $79.12.

What is the market capitalization of Zimmer Biomet Holdings Stock?
As of the Jul 23, 2026, the market capitalization of Zimmer Biomet Holdings is 17.344B.

When is the next earnings date for Zimmer Biomet Holdings?
The upcoming earnings date for Zimmer Biomet Holdings is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT ZIMMER BIOMET HOLDINGS
Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices an...
GOLDEN STAR
Ticker Change Signal Date
I
INTR
$5.62
1.25% Jul 20
DHT
$17.31
4.74% Jul 13
JLL
$299.78
8.09% Jun 24
NMRK
$15.02
2.13% Jun 24
ROP
$331.60
1.54% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE